Perrigo | PRGO - Bénéfice Avant Impôts





Bénéfice Avant Impôts Changement Date
AbbVie USD 7.87B 253M 2026-09
Abbott USD 2.92B 535M 2026-09
Bayer EUR 321M 2.67B 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Coherus Biosciences USD -46.35M 90.86M 2025-12
Corcept Therapeutics USD -44.72M 54.62M 2026-03
Dr.Reddys Laboratories INR 5.54B 955M 2026-06
Eli Lilly USD 8.79B 457M 2026-09
J&J USD 7.67B 988M 2026-09
Merck USD -683M 2.85B 2026-06
Nestle CHF 6.77B 475M 2026-06
Pacira USD 2.55M 2.44M 2026-06
Perrigo USD 105.4M 513.9M 2026-06
Pfizer USD -653M 5.84B 2026-06
Phibro Animal Health USD 38.62M 1.26M 2025-12
Prestige Brands USD 64.77M 2.96M 2026-03
Reckitt Benckiser GBP 1.54B 73M 2025-06
Sanofi EUR 5.28B 4.44B 2026-09
Supernus Pharmaceuticals USD 22.71M 80.36M 2026-09
Teva Pharmaceutical Industries USD -455M 1.21B 2026-06
Xeris Pharmaceuticals USD -31.1M 33.34M 2026-06
Zoetis USD 758M 3M 2026-03